Bet v 4.0101 Antigen

<strong>Bet v 4.0101 Antigen</strong>_x000D_ <strong>Catalog number:</strong> B2013517_x000D_ <strong>Lot number:</strong> Batch Dependent_x000D_ <strong>Expiration Date:</strong> Batch dependent_x000D_ <strong>Amount:</strong> 0.1 mg_x000D_ <strong>Molecular Weight or Concentration:</strong> 10 kDa_x000D_ <strong>Supplied as:</strong> Solution_x000D_ <strong>Applications:</strong> molecular tool for various biochemical applications_x000D_ <strong>Storage:</strong> -20°C_x000D_ <strong>Keywords:</strong> Bet v 4.0101_x000D_ <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity &gt;18 MΩ-cm) and are filtered through 0.22 um._x000D_ _x000D_ <strong>References:</strong>_x000D_ 1: Stewart A, Ferguson C. Towards evidence-based emergency medicine: best BETs from the Manchester Royal Infirmary. BET 4: Alpha blockers v calcium blockers to increase spontaneous passage of renal calculi Emerg Med J. 2013 Feb;30(2):168-9._x000D_ 2: Wangorsch A, Jamin A, Foetisch K, Malczyk A, Reuter A, Vierecke S, Schülke S, Bartel D, Mahler V, Lidholm J, Vieths S, Scheurer S. Identification of Sola l 4 as Bet v 1 homologous pathogenesis related-10 allergen in tomato fruits Mol Nutr Food Res. 2015 Mar;59(3):582-92._x000D_ 3: Li L, Chang C, Guan K. Birch Pollen Allergens Curr Protein Pept Sci. 2022;23(11):731-743._x000D_ 4: Groh N, von Loetzen CS, Subbarayal B, Möbs C, Vogel L, Hoffmann A, Fötisch K, Koutsouridou A, Randow S, Völker E, Seutter von Loetzen A, Rösch P, Vieths S, Pfützner W, Bohle B, Schiller D. IgE and allergen-specific immunotherapy-induced IgG(4) recognize similar epitopes of Bet v 1, the major allergen of birch pollen Clin Exp Allergy. 2017 May;47(5):693-703._x000D_ 5: Ciprandi G, Silvestri M, Pistorio A, Olcese R, Del Barba P, Tosca MA. Bet v 1 sensitization modulates allergenic molecular immune response Eur Ann Allergy Clin Immunol. 2019 Jan;51(1):21-31._x000D_ 6: Dehus O, Zimmer J, Döring S, Führer F, Hanschmann KM, Holzhauser T, Neske F, Strecker D, Trösemeier JH, Vieths S, Kaul S. Development and in-house validation of an allergen-specific ELISA for quantification of Bet v 4 in diagnostic and therapeutic birch allergen products Anal Bioanal Chem. 2015 Feb;407(6):1673-83._x000D_ 7: Engel E, Richter K, Obermeyer G, Briza P, Kungl AJ, Simon B, Auer M, Ebner C, Rheinberger HJ, Breitenbach M, Ferreira F. Immunological and biological properties of Bet v 4, a novel birch pollen allergen with two EF-hand calcium-binding domains J Biol Chem. 1997 Nov 7;272(45):28630-7._x000D_ 8: Köhler VK, Crescioli S, Fazekas-Singer J, Bax HJ, Hofer G, Pranger CL, Hufnagl K, Bianchini R, Flicker S, Keller W, Karagiannis SN, Jensen-Jarolim E. Filling the Antibody Pipeline in Allergy: PIPE Cloning of IgE, IgG(1) and IgG(4) against the Major Birch Pollen Allergen Bet v 1 Int J Mol Sci. 2020 Aug 8;21(16):5693._x000D_ 9: Cudowska B, Kapingidza AB, PawÅ‚owicz M, Pampuch A, Hyduke N, Pote S, Schlachter CR, Lebensztejn DM, Chruszcz M, Kowal K. Production and Use of Recombinant Profilins Amb a 8, Art v 4, Bet v 2, and Phl p 12 for Allergenic Sensitization Studies Molecules. 2020 Jan 16;25(2):369._x000D_ <a href="https://pubmed.ncbi.nlm.nih.gov/27470643">10: Ciprandi G, Comite P, Mussap M, De Amici M, Quaglini S, Barocci F, Marseglia GL, Scala E. Profiles of Birch Sensitization (Bet v 1, Bet v 2, and Bet v 4) and Oral Allergy Syndrome Across Italy J Investig Allergol Clin Immunol. 2016;26(4):244-8. </a>_x000D_ _x000D_ <strong>Products Related to Bet v 4.0101 Antigen can be found at</strong> <a href="https://moleculardepot.com/product-category/Proteins/"> Proteins</a>